VCDraft

Add Company

Company

Sign in Sign up

VCDraft

© 2025 VC Draft. All rights reserved.

Alentis Therapeutics

Biopharma specializing in advanced therapeutic antibodies.

Valuation

$181M

Founded Year

2019

Location

Basel(Switzerland)

Industry

Portfolios

Valuation

Alentis Therapeutics was last valued at $181M (Jan 2024)

Increased by 72% since inception

Jan 2023 - Jan 2024

Similar Companies

Portfolios

0

Alentis Therapeutics: $181M valuation with 72% growth | VC Draft

Intarcia

$5B

Caris Life Sciences

$7.8B

Ori Biotech

$100M

Perfect Day

$1.6B